Current trends in the real-life use of dalbavancin: report of a study panel-Reference-Cited by-同舟云学术

Current trends in the real-life use of dalbavancin: report of a study panel

Published:2020-10 Issue:4 Volume:56 Page:106107
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Durante-Mangoni Emanuele,Gambardella Michele,Iula Vita Dora,De Stefano Giulio Francesco,Corrado Mariano Franco,Esposito Vincenzo,Gentile Ivan^ORCID,Coppola Nicola

Funder

Angelini Pharma

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference48 articles.

1. New lipoglycopeptides: a comparative review of dalbavancin, oritavancin and telavancin;Zhanel;Drugs,2010

2. Dalbavancin: a novel lipoglycopeptide antibiotic with extended activity against Gram-positive infections;Smith;Infect Dis Ther,2015

3. Dalbavancin: a new lipoglycopeptide antibiotic;Bailey;Am J Health Syst Pharm,2008

4. Surveillance of antimicrobial resistance in Europe 2018,2019

5. Management of multidrug-resistant enterococcal infections;Arias;Clin Microbiol Infect,2010

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy of dalbavancin and impact on hospitalization and treatment costs in patients with ABSSSI;Global and Regional Health Technology Assessment;2024-07-29

2. Expert Opinion on Dose Regimen and Therapeutic Drug Monitoring for Long-Term Use of Dalbavancin: Expert Review Panel;International Journal of Antimicrobial Agents;2023-11

3. Biochemistry, mechanistic intricacies, and therapeutic potential of Antimicrobial Peptides: an alternative to traditional Antibiotics;Current Medicinal Chemistry;2023-10-10

4. Real-World Data Regarding Dalbavancin Use before and during the COVID-19 Pandemic—A Single-Center Retrospective Study;Antibiotics;2023-07-19

5. Direct or early Discharge of Acute Bacterial Skin and Skin Structure Infection patients from the Emergency Department/Unit: place in therapy of dalbavancin;Expert Review of Anti-infective Therapy;2023-05-31